Erratum: Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study

Erratum: Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-07-01
Series:	Journal of Human Reproductive Sciences
Online Access:	https://journals.lww.com/10.4103/0974-1208.386502
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study
by: Nayana Hitesh Patel, et al.
Published: (2023-04-01)

Experimental investigation of the mechanical properties of Alfas stone
by: Konstas N. Kaklis, et al.
Published: (2017-04-01)

Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks versus Epoetin Alfa Every Week for Cancer Patients with Anemia due to the Effect of Concomitant Myelosuppressive Chemotherapy
by: November McGarvey, et al.
Published: (2015-11-01)

Alfa-Fetoprotein-Producing Female Primary Urethral Adenocarcinoma with Neuroendocrine Differentiation
by: Takao Natsuyama, et al.
Published: (2019-01-01)

Pokolenie Alfa w szkole. Działania projektowo-wdrożeniowe z wykorzystaniem ICT
by: Eunika Baron-Polańczyk, et al.
Published: (2022-12-01)

The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
by: Mario Pezzi, et al.
Published: (2020-01-01)

Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa
by: Hajime Kato, et al.
Published: (2021-01-01)

Additive Effect of Dornase Alfa and Nacystelyn on Transportability and Viscoelasticity of Cystic Fibrosis Sputum
by: Feng Sun, et al.
Published: (2002-01-01)

QSAR modelling and docking analysis of some thiazole analogues as alfa-glucosidase inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2019-06-01)

Experimental and Numerical Analyses of Alfa/Polyester Composite Under Three-Point Bending
by: Mokhtar Belkacem, et al.
Published: (2025-04-01)

Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
by: Leonard D’Amico, et al.
Published: (2025-02-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-03-01)

ALFA e BETO: como avaliar leitura e escrita na Educação Infantil?
by: Magna do Carmo Silva, et al.
Published: (2020-05-01)

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
by: R. Rodríguez-Lojo, et al.
Published: (2010-01-01)

De alfa a omega: Estimación de la confiabilidad ordinal. Una guía práctica
by: Nicolás Vizioli, et al.
Published: (2022-12-01)

Effects of MAPP Compatibilization and Acetylation Treatment Followed by Hydrothermal Aging on Polypropylene Alfa Fiber Composites
by: Noura Hamour, et al.
Published: (2015-01-01)

Andexanet alfa for oral fxa inhibitor-associated major acute intracerebral hemorrhage: insights into clinically relevant thromboembolic events from the ANNEXA-I study
by: Mateo Porres-Aguilar, et al.
Published: (2025-01-01)

Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
by: Bruno Fautrel, et al.
Published: (2024-10-01)

Ductus Venosus Doppler S/D Value Adjusted Alfa Fetoprotein Levels to Decrease False Positive Rates
by: Alptekin Tosun, et al.
Published: (2013-12-01)

¿Por qué es importante reportar los intervalos de confianza del coeficiente alfa de Cronbach?
by: Sergio Alexis Domínguez-Lara, et al.
Published: (2015-01-01)

Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis
by: Safak Kaya, et al.
Published: (2015-01-01)

Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph
by: Dougald M. Monroe, et al.
Published: (2016-01-01)

Assessing the effectiveness of the SOLIO Alfa Cure Plus device in treating low back pain: a randomized controlled study
by: Hadari Yotam, et al.
Published: (2025-01-01)

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG?
by: S. V. Orlov, et al.
Published: (2016-06-01)

Hubungan Tumor Necrosis Factor-Alfa (Tnf-A) dengan Kadar Hemoglobin dan Parasitemia pada Infeksi Malaria Falciparum
by: Lili Irawati
Published: (2014-05-01)

DETERMINACIÓN DE LAS PROPIEDADES DE LA ENZIMA ALFA AMILASA PARA SU USO EN LA INDUSTRIA AZUCARERA
by: Saul Dueñas Casas, et al.
Published: (2024-12-01)

Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study
by: Clare Harris, et al.
Published: (2023-01-01)

Efecto del ácido alfa lipoico sobre la peroxidación no enzimática en mitocondrias de corazón y cerebro de rata
by: M. Marmunti, et al.
Published: (2021-01-01)

Rare Form of Erdheim-Chester Disease Presenting with Isolated Central Skeletal Lesions Treated with a Combination of Alfa-Interferon and Zoledronic Acid
by: E. N. Bulycheva, et al.
Published: (2015-01-01)

Pre-failure indicators detected by Acoustic Emission: Alfas stone, cement-mortar and cement-paste specimens under 3-point bending
by: Stavros K. Kourkoulis, et al.
Published: (2017-04-01)

Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent
by: Anurag Polavarapu, et al.
Published: (2015-01-01)

Efficacy and Tolerability of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency at a Hospital Outpatient Clinic: A Retrospective Cohort Study of Real-World Clinical Practice
by: António Robalo Nunes, et al.
Published: (2017-01-01)

The clinical profile and outcome of patients receiving continuation electroconvulsive therapy (C-ECT): A retrospective study
by: Sandeep Grover, et al.
Published: (2023-06-01)

Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2
by: Naota Taura, et al.
Published: (2012-01-01)

Corrigendum to “Efficacy and Tolerability of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency at a Hospital Outpatient Clinic: A Retrospective Cohort Study of Real-World Clinical Practice”
by: António Robalo Nunes, et al.
Published: (2019-01-01)

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria
by: G. Rendl, et al.
Published: (2020-01-01)

Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
by: Mariana P. Miranda-Hernández, et al.
Published: (2018-01-01)

Clinical trial participation, clinical care, and patient outcomes by practice setting: a real-world database analysis of patients with Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma
by: Debora S. Bruno, et al.
Published: (2025-12-01)

TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial
by: Wei Gao, et al.
Published: (2025-02-01)

Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study
by: Barrachina Jordi, et al.
Published: (2022-12-01)